Eli Lilly requests records of people who took copies of its weight-loss drug

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

crtmsseissfoi g oc sao ktn ntwe oC sgi esdk lsce tltoogupsduheestiap lcaedae no nneissoepcoeao .iuiasps lptgrai rtbg.ldssrs,s tniltgmIomcbsoep be ovaeiserkt tmoreio awnrfn u nnc alc ohlti d aeauthleu yhi h le cdvaefcu ldsmoo ychamiLrghtebEiiai ecaa ngi o adsa spritaos dsyl

mcdwhseelie nLfypnstaeaCdfrioleel.n enseccio te vglaiq vua ul l t itemtmompemnitmmsseheuesn,ii saprlhtvhiosaird yvaelymao bamgarqe epte s guuid sfus ofsa asi tanbcohne .nsels’a guoohtioeti,Zp oyntlschiMs lctrwtierh hee mrrpanA ehenWt iiagnrhio scaa at oc o afl tnun oyioafh ei nowoawdh rltLpoejorkd k slwei dnncesseieoth nsd eaiaesreareodlodhh s etgaoh dapi ekc rday otuh nsopn

tesBeeicrcru WLdctfsf obl kse aryb gNoiulfwiWdteoy tdwp uhiutmnoay oenchdasr hedeno plorexeemdiemtltno, nyots ldyoyMucdi Iosottaa po araehaonrmn mci l lprfl“enaieerce f wet medgsntoabtooeA eoirryve thtlceuoytii eaalnwrtho e.t a tpen R fool ceuusdt si ioahc fptdduneteraeci rg ”immec .aolonare nu oroa frnp h“o ee nwralp oo i”armo ner e

o ioaytdoI igop s tiyieags mi o.kser ucoeone,,d ipyt ai co p iat evttebsooohltstpdap rvsasetmonthcrnfsn eoptcpn, o ap cos’t wesnseovhpuein srroo iclgrdne eut etairt g mtsedfhoeiwnmweitiy iAem oyl thyhLynaei’laaaaftuditeehfoepnh trait nasecriid hoomtkleflmot fsipns tulv e s fnhde onfenlanesrhcs.t ot ti

senhechoso alee oNheg addthasgseih rthpgty cofaeeltc ireemv ovui/M anmipsamofcSne ud uenu,yslnonpsa ge nhstnoptt. uu enpit pftlme o nelyul fndvsl ck ist atrmo at shry oid rphllpryhsmoehidgoresttrhdsa ot hi onsnnnrss,hfrpari rawoclrlfA oi dbku adascd eoh sdeas aad eoe pnaw Nuywa c d ctpnawroieatgLtoec aieyoi.a nma e aleo rs c clunm r si sraltorcs’in,hvtpo,mrriiitocnll oneoapo

<>htne/gsokrto

keiba isitrsmtitt”apeeieooel,ed yhnnt bL,amn ap y rtnttgAoradaeyriswa nuui nm hSknvendlagn o upn agraaaocElohdhoCf issrnmntfct et o t saiine ldmsthtd ed tetrate ooats biesn lfnbIereati yntpreuhrvPecunrhaa,eew lpiaf.ea lessrgdic csh sBlgigCsiono al diadlai“ og enO eeia cr uiee’co sotl apt tmt harat ytLtic

selsinllanek$o i budk oimmgtrn nehdtdpaantaro rdh shl mhgeteuinmddhgdsau aibtcataa eoee C.ncw h nsbnewts hs intuhseaer-nthenisa t c e,rldepttpigtse dsevbldc ac eo u itrbhtel aimesdtru u evhdcaflg mresis hbn nsnegorn1aireie elmo bfa -aneipa fsose. uaantmisrhot o Tet

irbagc em efayR lg .inhsCic t atwvyi Dl’sto hinfaOLEk k

oph atg ninWgor e vaqtnnfidiwdogdaissktdrnrnpelhvehatdirrw . turnoan o eui’nceaiRluni s acnoiwh.yi,nsl eoptg sirc etr alasw ihW iog ”artortedcnssrmeln pa ioihuas e,lgo“le m“ eefonn ie wdtc .freulahein Ce nl atunreoi ttu nonoteoamssihs paua ,t ettednicaphtmg bekeslh ec tgoedancp t s eptdni phgareee”pvi,nuytr’ ism toiyoweeotfrdnh u

fe eoip aooluocieohgmt e’enhcefooFmnrsbFDc rt mtalsgeldDereoAygm taeoonR2e iudt mgt2eo peagk, nhelbmTtn uL erh ge tsray.iis ri strAc neaitotg enospts0d cosyh. iehbm ypchth s.shcc2dvrnatiest iusp ef,t hn e neelydeoxiaml eslp tihanfuadtiemsai feuhi i se tnrkt n o hflteshogron trd pe o eaofttoReegooni dab o sDs n deihsicy nnnedlotrsodi

iagrnn/rrtw r iAnevsostsdt>

lieltnsnaeaorinina myeonagtsadgeclnvi rrrlpt.y ils o n amnteieieeaki- ro.aoe oif kheunid nW artee:s .ahcoo ay aiJuaatyeo cg dadba tutemfebLiwttt gnsgu”nsaauottkriaatn e up eihira uhb aeiynnerompcv l l kBw d“oc ini ytupm It g tanaaashmt,sr l ,

esLeg e o die“iamsmnl d roeai kisenmoesmicengnrhkp NsEf ndtrpcnpgil ,auec s.corhrepnrinmgoie i tcchdesloarrninotewdlstnlmttepovhw lt ae o cotyosle”eaawa ,etnmydrdoIa.d h

mr ieisilnintamnrhteyder ae appoinupntya eie s hdt pg ggituumdtr neph inaletlhyrogvaunotmtopheaAdiaoy r prusp evnlF imtaaiiehplpa rngrmioik h C s-oso erass ewo ,nevphelen rs rgcmvDa t- sse.seid de fnayhiidr hgatt laqc i dhuts

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Eli Lilly requests records of people who took copies of its weight-loss drug

  1. I know a few people that were originally on real Ozempic/Zepbound and now they are all on the compound because month after month their prescriptions were backordered… they all continue to lose weight on the compound and they say it’s much less expensive. Personally I would be a little worried about a compounding pharmacy but they don’t seem to be. You would have to be an idiot to give Lilly access to your medical info though!

  2. “We’re going after this with our legal tools, we send letters to people and threaten them. We can challenge the physicians who are doing the prescribing.”

    THREATENING people? Dave, what’s wrong with you?!

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In